Sign up now and fund within 24h to get free NKE, GPRO or DBX stock. T&Cs apply.
Redeem Now
Stake logo

ARK Genomic Revolution Multi-Sector ETF

1 day chart

Kickstart your portfolio with a U.S. stock on us

Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.

Sign up and fund a new Wall St account and get a full U.S. share.

T&Cs apply
Claim now
Kickstart your portfolio with a U.S. stock on us

About ARKG

ARKG is an actively managed ETF that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and U.S. exchange traded foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund’s investment theme of the genomics revolution.

Buy US stocks in Australia starting with ARKG. Open an account and start investing today!

Market Capitalisation

-

Price-earnings ratio

-

Dividend yield

0.00%

Volume

3.03M

High today

$26.68

Low today

$25.70

Open price

$26.60

52-week high

$38.97

52-week low

$21.97


What is ARKG (ARK Genomic Revolution ETF)?

Ever wonder what life will be like for you as you get older? Or for your grandchildren?

ARKG is an Exchange Traded Fund (ETF) actively managed by ARK Invest and comprised of companies primarily focused on improving and extending the quality of human and other life. 

These companies are achieving this via technological and scientific developments as well as genomic advancements in fields such as:

  • DNA sequencing 

  • Gene editing

  • Gene Therapy

  • Targeted therapeutics

  • Agricultural biology

  • Molecular diagnostics

Through ARKG, Ark Invest provides shareholders with multi-cap exposure for the purpose of returning long-term capital growth.

ARKK vs ARKG: What’s the difference between the two ETFs?

While both ARKG and ARKK are ETFs managed by Ark Invest, the theme of each ETF is different.

Securities within ARKG are all “genomics revolution” companies, focused on improving and extending quality of life. They may even reshape the nature of healthcare in the future.

ARKK invests in companies focused on the broader theme of “disruptive innovation.” These companies are seeking to potentially change the world through new technologically enabled products or services. Some of the areas ARKK focuses on include cloud computing, autonomous vehicles, robotics, energy storage, e-Commerce and digital media.

What is ARKG invested in?

As of March 2022, ARKG contains 52 securities based on the theme of the “genomics revolution.” The ARKG share price usually performs in line with these holdings.

Some of ARKG’s largest holdings include EXACT Sciences Corporation (9.56%), Teladoc Health (7.71%), Ionis Pharmaceuticals (5.92%), Fate Therapeutics (4.23%) and Pacific Biosciences of California (3.94%).

For the complete ARKG holdings list, click here.

Is ARKG invested in BNGO?

BioNano Genomics (BNGO) became a well known “meme stock” when social media users, in particular Reddit traders, bid the stock up over 1800% between the end of December 2020 and mid February 2021.

Ark Invest’s CEO Cathie Wood has expressed an interest in BioNano’s Saphyr optical genome mapping (OGM) system in the past. 

Speculators believed that Cathie Wood would add BNGO to ARKG in 2021. However, as of March 2022, ARKG does not appear to contain a position in BNGO.

As of March 2022, BNGO has dropped almost 90% since its meteoric rise.

Is ARKG a good ETF?

ARKG ETF is a good way for investors to gain exposure to a large range of genomics revolution companies without having to buy all the individual stocks.

Ready to start your investing journey with Stake?

Open an account

ARKG FAQs

Yes, the Stake platform allows you to buy ARKG shares and over 12,000 stocks and ETFs across the ASX and Wall St.

One share of ARK Genomic Revolution Multi-Sector ETF is valued at $25.86.

The ticker symbol for ARK Genomic Revolution Multi-Sector ETF is ARKG.

To buy ARKG stocks in Australia you'll need to open an account with an investing platform like Stake.
To do so follow these steps:
  1. Sign up in minutes, all you need is some I.D.
  2. Choose Stake Wall St
  3. Deposit directly into your Stake wallet and you're ready to invest in ARKG

The ARK Genomic Revolution Multi-Sector ETF 52-week high stock price is $38.97.

The ARK Genomic Revolution Multi-Sector ETF 52-week low stock price is $21.97.

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.

Invest in ARKG
on Stake

Buy ARKG from US$3 brokerage

Invest in 9,500+ U.S. stocks and ETFs

Own a slice of ARKG from only US$10 with fractional shares

Get started
Canstar award phone
ARKG related stocks

Stake logo
Over 7,000 5-star reviews
App Store logoGoogle Play logo

Subscribe to our free newsletters

By subscribing, you agree to our Privacy Policy.

Stakeshop Pty Ltd, trading as Stake, ACN 610105505, is an authorised representative (Authorised Representative No. 1241398) of Sanlam Private Wealth Pty Ltd (Australian Financial Services Licence No. 337927) ('Sanlam') and an authorised representative (Authorised Representative No. 1241398) of Airwallex Pty Ltd (Australian Financial Services Licence No. 487221) ('Airwallex'). Stake is not authorised by Airwallex under Airwallex’s AFSL to arrange for clients to be issued with securities as Airwallex is not authorised under its AFSL for this purpose. Stake is not authorised by Sanlam under Sanlam’s AFSL to arrange for clients to be issued with a non-cash payment facility as Sanlam is not authorised under its AFSL for this purpose. Stake SMSF Pty Ltd (‘Stake Super’) is not licensed to provide financial product advice under the Corporations Act. This specifically applies to any financial products which are established if you instruct Stake Super to set up a self managed super fund (‘SMSF’). When you sign up to Stake Super, you are contracting with Stake SMSF Pty Ltd who will assist in the establishment of a SMSF under a ‘no advice model’. You will also be referred to Stakeshop Pty Ltd to enable your trading account and bank account to be set up in order to use the Stake Website and/or App. Stakeshop Pty Ltd will also run marketing and promotions to you under. For more information about SMSFs, see our SMSF Risks page.The information on our website or our mobile application is not intended to be an inducement, offer or solicitation to anyone in any jurisdiction in which Stake is not regulated or able to market its services. At Stake and Stake Super, we’re focused on giving you a better investing experience but we don’t take into account your personal objectives, circumstances or financial needs. Any advice given by Stake is of a general nature only. As investments carry risk, before making any investment decision, please consider if it’s right for you and seek appropriate taxation and legal advice. Please view our Financial Services GuideTerms & ConditionsPrivacy Policy and Disclaimers  before deciding to invest on or use Stake or Stake Super. By using our website or service in any way, you agree to our Privacy Policy and Terms & Conditions. All financial products involve risk and you should ensure you understand the risks involved as certain financial products may not be suitable to everyone. Past performance of any product described on this website is not a reliable indication of future performance. Stake and Stake Super are registered trademarks in Australia.

Copyright © 2024 Stake. All rights reserved.